Fluidigm Sets IPO Pricing at $13.50 per Share
February 10, 2011
Fluidigm Sets IPO Pricing at $13.50 per Share
Fluidigm first disclosed its renewed IPO effort in early December, reviving plans for a public offering that the company put on hiatus in September 2008 amid the economic downturn.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Leerink Swann Downgrades Fluidigm, Noting Company's Shares May Take 'A Breather'
April 29, 2013 / GenomeWeb Daily News - Following IPO, Fluidigm Reports Double-Digit Revenue Growth for Q4, FY'10
March 10, 2011 / PCR Insider - Fluidigm Underwriters Exercise Over-allotment Option
February 16, 2011 / GenomeWeb Daily News - Fluidigm Prices IPO at $13.50 per Share
February 10, 2011 / GenomeWeb Daily News - Fluidigm Places Price Range of $13.50 to $15.50 per Share on IPO
January 28, 2011 / GenomeWeb Daily News